Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on ...

Sanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab ... suggests that overproduction of this chemical messenger is one of the causes for the ...

Nine justices in the US Supreme Court voted unanimously to uphold lower district and federal court rulings that invalidated the patents awarded to Amgen for Repatha (evolocumab), which the company ...